This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Michigan State University, University of California. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2020
Title: The Innovative Contributions of Nicole A Bakas
Introduction
Nicole A Bakas is a prominent inventor based in Victorville, California. She has made significant contributions to the field of pharmaceutical sciences, particularly through her work on immunoproteasome inhibitors. Her innovative approach has the potential to impact the treatment of various diseases and disorders.
Latest Patents
Nicole A Bakas holds a patent for "Immunoproteasome inhibitor analogs." This patent encompasses compounds that exhibit immunoproteasome inhibitory activity, along with pharmaceutical compositions derived from these compounds. The disclosure highlights the use of these compounds in treating a range of diseases and disorders associated with immunoproteasome activity, including inflammatory disorders, autoimmune disorders, hematological disorders, and neurodegenerative disorders. She has 1 patent to her name.
Career Highlights
Throughout her career, Nicole has worked with esteemed institutions such as the University of California and Michigan State University. Her research has focused on developing innovative solutions to complex health issues, showcasing her dedication to advancing medical science.
Collaborations
Nicole has collaborated with notable professionals in her field, including Michael C Pirrung and Andre Bachmann. These partnerships have further enriched her research and contributed to her success as an inventor.
Conclusion
Nicole A Bakas exemplifies the spirit of innovation in the pharmaceutical industry. Her work on immunoproteasome inhibitors not only highlights her expertise but also underscores the importance of research in addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile